Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3744 | 1919 | 29.7 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
62 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//HEART FAILURE//PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 86105 |
2676 | 2 | LEVOSIMENDAN//CALCIUM SENSITIZER//MILRINONE | 3400 |
3744 | 1 | ENOXIMONE//MILRINONE//AMRINONE | 1919 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ENOXIMONE | authKW | 602875 | 3% | 63% | 60 |
2 | MILRINONE | authKW | 547907 | 5% | 33% | 104 |
3 | AMRINONE | authKW | 402066 | 3% | 52% | 49 |
4 | PHOSPHODIESTERASE III INHIBITOR | authKW | 203630 | 1% | 53% | 24 |
5 | OLPRINONE | authKW | 133552 | 1% | 44% | 19 |
6 | PIROXIMONE | authKW | 117155 | 0% | 82% | 9 |
7 | PHOSPHODIESTERASE INHIBITORS | authKW | 114518 | 4% | 9% | 84 |
8 | R80122 | authKW | 79552 | 0% | 100% | 5 |
9 | E 1020 | authKW | 63641 | 0% | 100% | 4 |
10 | SATERINONE | authKW | 63641 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 20646 | 41% | 0% | 784 |
2 | Pharmacology & Pharmacy | 7135 | 36% | 0% | 699 |
3 | Chemistry, Medicinal | 2714 | 12% | 0% | 225 |
4 | Anesthesiology | 2028 | 6% | 0% | 124 |
5 | Peripheral Vascular Diseases | 1747 | 9% | 0% | 182 |
6 | Critical Care Medicine | 762 | 4% | 0% | 81 |
7 | Respiratory System | 529 | 5% | 0% | 94 |
8 | Medicine, General & Internal | 117 | 5% | 0% | 103 |
9 | Chemistry, Multidisciplinary | 40 | 6% | 0% | 121 |
10 | Surgery | 15 | 4% | 0% | 76 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANAESTHESIA INTENS CARE EMERGENCY CARE PAI | 15910 | 0% | 100% | 1 |
2 | CARDIO GRP | 15910 | 0% | 100% | 1 |
3 | CARDIOMYOPATHY TRANSPLANT | 15910 | 0% | 100% | 1 |
4 | CARDIOVASC ENS CARE UNIT | 15910 | 0% | 100% | 1 |
5 | CATTEDRA CARDOL | 15910 | 0% | 100% | 1 |
6 | CINCINNATI CHILDRENS HOSP MED CLIN PHARMA | 15910 | 0% | 100% | 1 |
7 | CIRULATORY PHYSIOL | 15910 | 0% | 100% | 1 |
8 | CLIN PHARMA PROGRAM | 15910 | 0% | 100% | 1 |
9 | CLIN PHYSIOL CARDIOVASC | 15910 | 0% | 100% | 1 |
10 | CLIN PRACTICE INTEGRAT | 15910 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 25501 | 7% | 1% | 133 |
2 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 12526 | 3% | 1% | 59 |
3 | ZEITSCHRIFT FUR KARDIOLOGIE | 11426 | 3% | 1% | 54 |
4 | AMERICAN HEART JOURNAL | 5995 | 4% | 1% | 74 |
5 | AMERICAN JOURNAL OF CARDIOLOGY | 5284 | 5% | 0% | 95 |
6 | CARDIOVASCULAR DRUGS AND THERAPY | 3938 | 1% | 1% | 22 |
7 | HERZ KREISLAUF | 3171 | 1% | 1% | 14 |
8 | PHARMAZIE | 3090 | 2% | 0% | 42 |
9 | CIRCULATION | 2844 | 3% | 0% | 67 |
10 | CARDIOVASCULAR DRUG REVIEWS | 1842 | 0% | 2% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENOXIMONE | 602875 | 3% | 63% | 60 | Search ENOXIMONE | Search ENOXIMONE |
2 | MILRINONE | 547907 | 5% | 33% | 104 | Search MILRINONE | Search MILRINONE |
3 | AMRINONE | 402066 | 3% | 52% | 49 | Search AMRINONE | Search AMRINONE |
4 | PHOSPHODIESTERASE III INHIBITOR | 203630 | 1% | 53% | 24 | Search PHOSPHODIESTERASE+III+INHIBITOR | Search PHOSPHODIESTERASE+III+INHIBITOR |
5 | OLPRINONE | 133552 | 1% | 44% | 19 | Search OLPRINONE | Search OLPRINONE |
6 | PIROXIMONE | 117155 | 0% | 82% | 9 | Search PIROXIMONE | Search PIROXIMONE |
7 | PHOSPHODIESTERASE INHIBITORS | 114518 | 4% | 9% | 84 | Search PHOSPHODIESTERASE+INHIBITORS | Search PHOSPHODIESTERASE+INHIBITORS |
8 | R80122 | 79552 | 0% | 100% | 5 | Search R80122 | Search R80122 |
9 | E 1020 | 63641 | 0% | 100% | 4 | Search E+1020 | Search E+1020 |
10 | SATERINONE | 63641 | 0% | 100% | 4 | Search SATERINONE | Search SATERINONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FISCHER, TA , ERBEL, R , TREESE, N , (1992) CURRENT STATUS OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE.DRUGS. VOL. 44. ISSUE 6. P. 928-945 | 111 | 82% | 23 |
2 | COLUCCI, WS , WRIGHT, RF , BRAUNWALD, E , (1986) NEW POSITIVE INOTROPIC AGENTS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - MECHANISMS OF ACTION AND RECENT CLINICAL DEVELOPMENTS .2..NEW ENGLAND JOURNAL OF MEDICINE. VOL. 314. ISSUE 6. P. 349-358 | 86 | 96% | 272 |
3 | HOOD, WB , (1989) CONTROLLED AND UNCONTROLLED STUDIES OF PHOSPHODIESTERASE-III INHIBITORS IN CONTEMPORARY CARDIOVASCULAR MEDICINE.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 63. ISSUE 2. P. A46-A53 | 80 | 100% | 25 |
4 | VERNON, MW , HEEL, RC , BROGDEN, RN , (1991) ENOXIMONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL.DRUGS. VOL. 42. ISSUE 6. P. 997-1017 | 63 | 91% | 24 |
5 | YOUNG, RA , WARD, A , (1988) MILRINONE - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 36. ISSUE 2. P. 158-192 | 65 | 94% | 57 |
6 | OSADCHII, OE , (2007) MYOCARDIAL PHOSPHODIESTERASES AND REGULATION OF CARDIAC CONTRACTILITY IN HEALTH AND CARDIAC DISEASE.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 21. ISSUE 3. P. 171 -194 | 77 | 34% | 42 |
7 | OM, A , HESS, ML , (1993) INOTROPIC THERAPY OF THE FAILING MYOCARDIUM.CLINICAL CARDIOLOGY. VOL. 16. ISSUE 1. P. 5-14 | 56 | 69% | 7 |
8 | ARNOLD, JMO , (1993) THE ROLE OF PHOSPHODIESTERASE INHIBITORS IN HEART-FAILURE.PHARMACOLOGY & THERAPEUTICS. VOL. 57. ISSUE 2-3. P. 161-170 | 51 | 74% | 11 |
9 | LEIER, CV , BINKLEY, PF , (1998) PARENTERAL INOTROPIC SUPPORT FOR ADVANCED CONGESTIVE HEART FAILURE.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 41. ISSUE 3. P. 207 -224 | 44 | 63% | 56 |
10 | CHANG, AC , ATZ, AM , WERNOVSKY, G , BURKE, RP , WESSEL, DL , (1995) MILRINONE - SYSTEMIC AND PULMONARY HEMODYNAMIC-EFFECTS IN NEONATES AFTER CARDIAC-SURGERY.CRITICAL CARE MEDICINE. VOL. 23. ISSUE 11. P. 1907-1914 | 33 | 85% | 89 |
Classes with closest relation at Level 1 |